Compare TWST & AXTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TWST | AXTI |
|---|---|---|
| Founded | 2013 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.9B |
| IPO Year | 2018 | 1998 |
| Metric | TWST | AXTI |
|---|---|---|
| Price | $47.96 | $64.24 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 3 |
| Target Price | ★ $46.25 | $24.50 |
| AVG Volume (30 Days) | 1.0M | ★ 12.5M |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 63.89 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $376,572,000.00 | $99,361,000.00 |
| Revenue This Year | $18.91 | $44.70 |
| Revenue Next Year | $15.07 | $42.23 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 20.32 | ★ 31.09 |
| 52 Week Low | $23.30 | $1.13 |
| 52 Week High | $57.88 | $71.49 |
| Indicator | TWST | AXTI |
|---|---|---|
| Relative Strength Index (RSI) | 50.54 | 60.69 |
| Support Level | $41.85 | $4.98 |
| Resistance Level | $57.88 | $71.49 |
| Average True Range (ATR) | 2.84 | 9.67 |
| MACD | 0.25 | -0.35 |
| Stochastic Oscillator | 43.44 | 80.47 |
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.